Partner

Melbourne

+61 3 8608 2754

Highly regarded

English


Jurisdictions:

Australia

Practice areas:

M&A

Industry sectors:

Healthcare


I advise Australian and international clients on mergers, acquisitions, divestments, restructures, capital raisings, joint ventures and other commercial contracts. My practice intersects with advising on the full spectrum of in-bound foreign investment and corporate governance issues that clients routinely encounter, including continuous disclosure, directors’ duties, shareholder activism, financial reporting and executive remuneration.

  • Essity Aktiebolag – advising the Stockholm listed company on its acquisition of Asaleo Care by scheme of arrangement, valued at $788 million.
  • Village Roadshow Limited – advised on its response to private equity acquisition proposals from Pacific Equity Partners and BGH Capital respectively, with BGH ultimately securing control of Village in a scheme transaction valued at $864 million – this deal successfully closed despite vigorous shareholder opposition from two activist shareholders.
  • Qualitas – advised the Australian fund manager, specialising in the commercial real estate sector, on its IPO and ASX listing.
  • CDH Investments and China Grand Pharmaceutical – advised on their successful A$1.9 billion acquisition of ASX listed Sirtex Medical Limited (this displaced an initially recommended A$1.50 billion offer from a first bidder).
  • Baosteel – advised on its successful A$1.4 billion joint takeover bid with Aurizon for ASX listed Aquila Resources and development of $8 billion West Pilbara Iron Ore Project.

  • Capital markets: Equity
  • Investment funds
  • M&A
  • Private equity

  • Construction and materials
  • Consumer goods and services
  • Food and beverage
  • Healthcare
  • Real estate

  • Member, Australian Takeovers Panel
  • Member, Corporations Committee of the Business Section of the Law Council of Australia